Initial Report on Safety and Lesion Response of Melanoma Brain Metastases After Stereotactic Radiosurgery or Hypofractionated Radiation Therapy in Patients Receiving Concurrent Pembrolizumab. Academic Article uri icon

Overview

publication date

  • October 1, 2016

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.ijrobp.2016.06.922

PubMed ID

  • 27673860

Additional Document Info

volume

  • 96

issue

  • 2S